PRICE T ROWE ASSOCIATES INC /MD/ - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 237 filers reported holding MIRATI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$105,983
+65.0%
2,433,029
+36.9%
0.02%
+77.8%
Q2 2023$64,224
-2.5%
1,777,579
+0.4%
0.01%
-10.0%
Q1 2023$65,844
+2.6%
1,770,941
+25.0%
0.01%0.0%
Q4 2022$64,191
-99.9%
1,416,728
+24.0%
0.01%
-23.1%
Q3 2022$79,811,000
+13.1%
1,142,755
+8.7%
0.01%
+44.4%
Q2 2022$70,589,000
-47.8%
1,051,530
-36.0%
0.01%
-35.7%
Q1 2022$135,187,000
-57.6%
1,644,216
-24.4%
0.01%
-51.7%
Q4 2021$319,021,000
-14.7%
2,174,799
+2.9%
0.03%
-17.1%
Q3 2021$374,025,000
+20.5%
2,114,210
+10.0%
0.04%
+20.7%
Q2 2021$310,425,000
+18.2%
1,921,779
+25.4%
0.03%
+11.5%
Q1 2021$262,517,000
-23.4%
1,532,500
-1.7%
0.03%
-25.7%
Q4 2020$342,510,000
+57.3%
1,559,416
+18.9%
0.04%
+40.0%
Q3 2020$217,735,000
+45.7%
1,311,262
+0.2%
0.02%
+31.6%
Q2 2020$149,432,000
+51.0%
1,308,852
+1.6%
0.02%
+18.8%
Q1 2020$98,981,000
-44.6%
1,287,645
-7.1%
0.02%
-30.4%
Q4 2019$178,520,000
+71.4%
1,385,379
+3.7%
0.02%
+53.3%
Q3 2019$104,132,000
-16.2%
1,336,564
+10.8%
0.02%
-11.8%
Q2 2019$124,233,000
+107.3%
1,206,144
+47.5%
0.02%
+88.9%
Q1 2019$59,932,000
+329.2%
817,628
+148.4%
0.01%
+350.0%
Q4 2018$13,963,000
-9.6%
329,160
+0.3%
0.00%0.0%
Q3 2018$15,450,000
+47.5%
328,024
+54.4%
0.00%0.0%
Q2 2018$10,475,000
+83.1%
212,465
+14.0%
0.00%
+100.0%
Q1 2018$5,720,000186,3200.00%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 2,881,702$14,985,0006.99%
Avoro Capital Advisors LLC 2,383,201$12,393,0001.58%
Broadfin Capital, LLC 2,090,801$10,872,0001.32%
Boxer Capital, LLC 1,037,994$5,398,0001.18%
Ghost Tree Capital, LLC 172,184$895,0000.17%
Baker Brothers Advisors 2,269,198$11,800,0000.10%
Hillhouse Capital Management 725,000$3,770,0000.07%
SABBY MANAGEMENT, LLC 249,735$1,299,0000.07%
Rhenman & Partners Asset Management AB 50,000$260,0000.04%
Trexquant Investment LP 42,879$223,0000.03%
View complete list of MIRATI THERAPEUTICS INC shareholders